| 9th Jan 2020 7:00 am |
RNS |
RXC007 nominated as drug development candidate |
| 7th Jan 2020 11:45 am |
RNS |
Form 8.5 (EPT/RI) |
| 6th Jan 2020 2:16 pm |
RNS |
Form 8.3 - Redx Pharma |
| 6th Jan 2020 11:45 am |
RNS |
Form 8.5 (EPT/RI) |
| 3rd Jan 2020 4:14 pm |
RNS |
Posting of Circular to Shareholders |
| 3rd Jan 2020 11:45 am |
RNS |
Form 8.5 (EPT/RI) |
| 2nd Jan 2020 2:44 pm |
RNS |
Form 8.3 - Redx Pharma plc |
| 2nd Jan 2020 12:57 pm |
GNW |
Form 8.3 - AXA INVESTMENT MANAGERS: Redx Pharma PLC |
| 2nd Jan 2020 11:45 am |
RNS |
Form 8.5 (EPT/RI) |
| 31st Dec 2019 7:00 am |
RNS |
Loan Capitalisation, GM Notice and Possible Offer |
| 19th Nov 2019 7:00 am |
RNS |
Redx & Medicines Discovery Catapult awarded grant |
| 7th Nov 2019 3:30 pm |
RNS |
Holding(s) in Company |
| 23rd Sep 2019 7:00 am |
RNS |
RXC006 poster presentation at ERS Congress |
| 19th Aug 2019 7:00 am |
RNS |
First cohort of patients dosed in RXC004 study |
| 18th Jul 2019 10:24 am |
EQS |
Hardman & Co Research: RedX Pharma (REDX): Pan-RAF agreement strengthens balance sheet |
| 11th Jul 2019 1:41 pm |
EQS |
Hardman & Co Research: Redx Pharma (REDX): Phase I trial resumed |
| 10th Jul 2019 7:00 am |
RNS |
Sale of pan-RAF inhibitor programme |
| 10th Jun 2019 7:01 am |
RNS |
Interim Results for six months ended 31 March 2019 |
| 10th Jun 2019 7:00 am |
RNS |
Short-term Debt Funding Secured |
| 3rd May 2019 11:34 am |
RNS |
Update on Plans to Strengthen Balance Sheet |
| 29th Mar 2019 7:00 am |
RNS |
Redx to present two posters at AACR 2019 |
| 28th Feb 2019 7:00 am |
RNS |
Issue of Warrants and Change to Lease Agreement |
| 14th Feb 2019 7:00 am |
RNS |
Directorate Update |
| 12th Feb 2019 7:00 am |
RNS |
New in vivo data on ROCK2 |
| 6th Feb 2019 11:25 am |
RNS |
Receipt of Outstanding Loan |
| 31st Jan 2019 7:00 am |
RNS |
Deinove return rights to Redx Programme |
| 23rd Jan 2019 11:25 am |
RNS |
Results of Annual General Meeting |
| 21st Jan 2019 7:00 am |
RNS |
RXC004 Trial Approval |
| 10th Jan 2019 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 10th Jan 2019 2:00 pm |
RNS |
Price Monitoring Extension |
| 3rd Jan 2019 7:00 am |
RNS |
Redx to present at 2019 Biotech Showcase event |
| 28th Dec 2018 11:47 am |
RNS |
Publication of Annual Report and Accounts |
| 30th Nov 2018 8:45 am |
EQS |
Hardman & Co Research: RedX Pharma (REDX): RXC006: First fibrosis development candidate |
| 30th Nov 2018 7:00 am |
RNS |
First RXC006 data for treatment of fibrosis |
| 27th Nov 2018 4:05 pm |
EQS |
Hardman & Co Research: Redx Pharma (REDX): Streamlined, focused and good value |
| 19th Nov 2018 7:00 am |
RNS |
CFO Announcement |
| 19th Nov 2018 7:00 am |
RNS |
Preliminary Results for year ended 30 Sept 2018 |
| 14th Nov 2018 7:00 am |
RNS |
Redx announces new drug development candidate |
| 9th Nov 2018 9:51 am |
EQS |
Hardman & Co Research: Redx Pharma (REDX):ROCK2 inhibitors in chronic kidney disease |
| 5th Nov 2018 7:00 am |
RNS |
Preclinical data presented at cancer conference |
